Gilead says 1Q sales of Sovaldi totaled $2.27B
AP - 34 mins ago
NEW YORK (AP) — Gilead Sciences said Tuesday that sales of its hepatitis C pill Sovaldi totaled more than $2 billion in its first full quarter on the market, and it said quarterly net income tripled.
Most active Nasdaq-traded stocks
AP - 49 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
Final Glance: Biotechnology companies
AP - 49 mins ago
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Stocks Rise In Higher Volume; Gilead Up After Hours
at Investor's Business Daily - 1 hr 37 mins ago
Stocks rose in higher volume Tuesday, with the Nasdaq and S&P 500 notching their sixth straight gains amid a flurry of buyout activity in the drugs industry. The Nasdaq rose 1%, while the S&P 500 and the Dow Jones industrial average each rose 0.4%....
Gilead Sciences Drops Jaws With a 209% Increase in Q1 Net Income
Sean Williams, The Motley Fool - Motley Fool - 1 hr 41 mins ago
Infectious disease-focused biopharmaceutical company Gilead Sciences did nothing short of dazzle Wall Street after the closing bell by reporting impressive top- and bottom-line growth in the first quarter . Total revenue for the quarter...
Will Gilead Sciences (GILD) Earnings Boost The Stock In After-Market Trading?
at The Street - 2 hrs 24 mins ago
Gilead Sciences (GILD) surpassed analysts first quarter estimates while nearly doubling year over year quarterly revenue.
Gilead Sciences Announces First Quarter 2014 Financial Results
Business Wire - 2 hrs 49 mins ago
--- Sovaldi Sales of $2.27 billion -
Nasdaq, S&P 500 On Track For Sixth Straight Gain
at Investor's Business Daily - Tue Apr 22, 2:30PM CDT
Stocks continued to hold near session highs late Tuesday, with the Nasdaq and S&P 500 on pace for their sixth straight gains. The Nasdaq was up 1.1%, while the Dow Jones industrial average and the S&P 500 rose 0.6% each. Volume was again running...
Biotech Earnings Preview
Brian Orelli, The Motley Fool - Motley Fool - Tue Apr 22, 1:00PM CDT
It's Fools' favorite time of the year: earnings season. In the video below, senior biotech specialist Brian Orelli and health-care bureau chief Max Macaluso discuss a few biotechs that will release first quarter earnings shortly. Gilead Sciences...
Midday Glance: Biotechnology companies
AP - Tue Apr 22, 12:19PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
3 Health Care Stocks Moving The Sector Upward
at The Street - Tue Apr 22, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.
Keep an Eye on these 3 Biotech Stocks - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 10:49AM CDT
This sell-off was more due to a change in sentiment rather than a shift in industry fundamentals.
Early Glance: Biotechnology companies
AP - Tue Apr 22, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Stock Market News for April 22, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 9:06AM CDT
Benchmarks ended in the green zone yesterday as investors were encouraged by better-than-expected corporate earnings results
Why Johnson & Johnson Is Outperforming the Dow
George Budwell, The Motley Fool - Motley Fool - Tue Apr 22, 8:30AM CDT
After setting record highs in 2013, the Dow Jones Industrials has largely traded sideways so far in recent months, down just 0.20% in 2014. Given the general weakness among health care stocks of late, you might suspect that pharma companies have...
Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis AG, and Gilead
George Budwell, The Motley Fool - Motley Fool - Tue Apr 22, 8:00AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Eli Lilly , GlaxoSmithKline plc , Novartis AG and Gilead Sciences . Novartis brokers multibillion dollar deals with Eli Lilly and GlaxoSmithKline ...
Why Earnings Season Could Be Great for Gilead Sciences (GILD) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 22, 7:54AM CDT
Investors are always looking for stocks that are poised to beat at earnings season and Gilead Sciences may be one such company as the firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Amgen, AT&T and Yum! Brands Lead Today's Earnings: Crunching the Numbers
at The Street - Tue Apr 22, 7:51AM CDT
Cree, Discover, Gilead Sciences, Intuitive Surgical, Juniper Networks, Skyworks Solutions and VMWare also report earnings after the closing bell today.
Gilead Sovaldi Drug Sales Key In Q1 Earnings Report
at Investor's Business Daily - Mon Apr 21, 5:34PM CDT
In a week filled with earnings reports from big-cap biotechs, Gilead Sciences' (GILD) might be the most watched as it reveals its first full quarter of sales for blockbuster hepatitis C drug Sovaldi. Gilead reports after the market close Tuesday....